A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)
Clinical trial NCT01557504 · COMPLETED
Trial details
- NCT number
- NCT01557504
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-18
- Primary completion
- 2014-04-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.